| Title |
Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, September 2012
|
| DOI | 10.1002/14651858.cd009159.pub2 |
| Pubmed ID | |
| Authors |
Sebastian Theurich, Hans Fischmann, Alexander Shimabukuro-Vornhagen, Jens M Chemnitz, Udo Holtick, Christof Scheid, Nicole Skoetz, Michael von Bergwelt-Baildon |
| Abstract |
Allogeneic haematopoietic stem cell transplantation (HSCT) is an established treatment for many malignant and non-malignant haematological disorders. Graft-versus-host disease (GVHD), a condition frequently occurring after HSCT, is the result of host tissues being attacked by donor immune cells. One strategy for the prevention of GVHD is the administration of anti-thymocyte globulins (ATG), a set of polyclonal antibodies directed against a variety of immune cell epitopes, leading to immunosuppression and immunomodulation. |
Twitter Demographics
The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 175 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Netherlands | 1 | <1% |
| Germany | 1 | <1% |
| Unknown | 172 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 28 | 16% |
| Student > Bachelor | 27 | 15% |
| Researcher | 21 | 12% |
| Student > Ph. D. Student | 17 | 10% |
| Student > Postgraduate | 13 | 7% |
| Other | 26 | 15% |
| Unknown | 43 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 76 | 43% |
| Nursing and Health Professions | 12 | 7% |
| Biochemistry, Genetics and Molecular Biology | 8 | 5% |
| Immunology and Microbiology | 7 | 4% |
| Agricultural and Biological Sciences | 6 | 3% |
| Other | 21 | 12% |
| Unknown | 45 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2012.
All research outputs
#18,314,922
of 22,678,224 outputs
Outputs from Cochrane database of systematic reviews
#11,415
of 12,298 outputs
Outputs of similar age
#128,343
of 168,582 outputs
Outputs of similar age from Cochrane database of systematic reviews
#212
of 226 outputs
Altmetric has tracked 22,678,224 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,298 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 2nd percentile – i.e., 2% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,582 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 226 others from the same source and published within six weeks on either side of this one. This one is in the 3rd percentile – i.e., 3% of its contemporaries scored the same or lower than it.